Upgrade to SI Premium - Free Trial

H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)

June 24, 2026 6:43 AM
H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating and $140.00 price target on Incyte (NASDAQ: INCY).The analyst commented: "Opzelura ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments